Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Sep-21 9:59 AM View:  | Translate Bio, Inc. (TBIO) | 14-Sep-21 | Market Purchase | 71,983,600 | $38.00 | $2,735,379,968.00 | 1954% 3.68M to 75.67M | (2%) |
| 02-Aug-21 8:34 PM View: | Icosavax, Inc. (ICVX) | 02-Aug-21 | Conversion | 3,088,500 | -- | -- | 100% 0 to 3.09M | |
| 02-Aug-21 8:34 PM View: | Icosavax, Inc. (ICVX) | 02-Aug-21 | Purchase | 66,667 | $15.00 | $1,000,000.00 | 2% 3.09M to 3.16M | |
| 29-Jul-20 6:06 AM View: | Inozyme Pharma, Inc. (INZY) | 28-Jul-20 | Conversion | 438,875 | -- | -- | 100% 0 to 438.88K | |
| 29-Jul-20 6:06 AM View: | Inozyme Pharma, Inc. (INZY) | 28-Jul-20 | Purchase | 81,250 | $16.00 | $1,300,000.00 | 19% 438.88K to 520.13K | |
| 11-Jun-20 6:45 PM View: | Regeneron Pharmaceuticals I... (REGN) | 09-Jun-20 | Market Sale | 120,234 | $597.48 | $71,837,400.00 | (30%) 400.0K to 279.77K | 18% |
| 29-May-20 4:16 PM View: | Regeneron Pharmaceuticals I... (REGN) | 29-May-20 | Sale | 20,421,900 | $509.85 | $10,412,099,584.00 | (88%) 23.22M to 2.8M | |
| 29-May-20 4:16 PM View: | Regeneron Pharmaceuticals I... (REGN) | 29-May-20 | Sale | 2,399,550 | $509.85 | $1,223,410,048.00 | (86%) 2.8M to 400.0K | |
| 11-Mar-20 5:00 PM View: | Regeneron Pharmaceuticals I... (REGN) | 09-Mar-20 | Market Sale | 128,914 | $489.65 | $63,123,200.00 | (< 1%) 23.35M to 23.22M | < 1% |
| 12-Sep-19 5:00 PM View: | Regeneron Pharmaceuticals I... (REGN) | 10-Sep-19 | Market Sale | 172,904 | $281.15 | $48,611,800.00 | (< 1%) 23.52M to 23.35M | (74%) |
| 23-Jul-19 11:39 AM View: | Fulcrum Therapeutics, Inc. (FULC) | 22-Jul-19 | Conversion Duplicate | 464,285 | -- | -- | 100% 0 to 464.29K | |
| 23-Jul-19 11:39 AM View: | Fulcrum Therapeutics, Inc. (FULC) | 22-Jul-19 | Purchase | 93,750 | $16.00 | $1,500,000.00 | 20% 464.29K to 558.03K | |
| 12-Mar-19 8:19 PM View: | Regeneron Pharmaceuticals I... (REGN) | 08-Mar-19 | Market Sale | 131,115 | $412.17 | $54,041,300.00 | (< 1%) 23.65M to 23.52M | (19%) |
| 15-Feb-19 6:05 AM View: | Myokardia, Inc. (MYOK) | 13-Feb-19 | Market Sale | 4,168,900 | $37.66 | $157,000,992.00 | (100%) 4.17M to 0 | (13%) |
| 10-Sep-18 5:01 PM View: | Regeneron Pharmaceuticals I... (REGN) | 06-Sep-18 | Market Sale | 104,552 | $406.68 | $42,519,200.00 | (< 1%) 23.76M to 23.65M | (20%) |
| 11-Jun-18 4:30 PM View: | Regeneron Pharmaceuticals I... (REGN) | 08-Jun-18 | Market Sale | 121,601 | $309.31 | $37,611,900.00 | (< 1%) 23.88M to 23.76M | (58%) |
| 29-May-18 4:34 PM View: | Myokardia, Inc. (MYOK) | 25-May-18 | Market Purchase | 150,000 | $49.00 | $7,350,000.00 | 4% 4.02M to 4.17M | (13%) |
| 29-Aug-17 5:00 PM View: | Regeneron Pharmaceuticals I... (REGN) | 25-Aug-17 | Market Purchase | 72,378 | $481.36 | $34,840,100.00 | < 1% 23.81M to 23.88M | 2% |
| 25-Aug-17 5:00 PM View: | Regeneron Pharmaceuticals I... (REGN) | 24-Aug-17 | Market Purchase | 105,820 | $482.04 | $51,009,600.00 | < 1% 23.7M to 23.81M | 1% |
| 25-Aug-17 5:00 PM View: | Regeneron Pharmaceuticals I... (REGN) | 23-Aug-17 | Market Purchase | 60,595 | $478.98 | $29,024,000.00 | < 1% 23.64M to 23.7M | 2% |
| 16-Aug-17 7:31 AM View: | Myokardia, Inc. (MYOK) | 14-Aug-17 | Market Purchase | 350,000 | $35.50 | $12,425,000.00 | 10% 3.67M to 4.02M | 20% |
| 06-Jun-17 5:00 PM View: | Regeneron Pharmaceuticals I... (REGN) | 02-Jun-17 | Market Purchase | 136,050 | $478.17 | $65,055,600.00 | < 1% 23.51M to 23.64M | 2% |
| 01-Jun-17 7:41 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 31-May-17 | Market Purchase | 297,501 | $71.87 | $21,381,400.00 | 3% 10.26M to 10.55M | 16% |
| 13-Jan-17 4:15 PM View: | Regeneron Pharmaceuticals I... (REGN) | 11-Jan-17 | Market Purchase | 87,298 | $369.71 | $32,274,900.00 | < 1% 23.42M to 23.51M | 32% |
| 05-Oct-16 9:00 AM View: | Myokardia, Inc. (MYOK) | 03-Oct-16 | Market Purchase | 450,000 | $15.00 | $6,750,000.00 | 14% 3.22M to 3.67M | 182% |
| 16-Jun-16 5:47 PM View: | Regeneron Pharmaceuticals I... (REGN) | 14-Jun-16 | Market Purchase | 64,731 | $363.86 | $23,552,900.00 | < 1% 23.35M to 23.42M | 34% |
| 18-Feb-16 5:45 PM View: | Regeneron Pharmaceuticals I... (REGN) | 17-Feb-16 | Market Purchase | 80,000 | $393.71 | $31,496,700.00 | < 1% 23.27M to 23.35M | 24% |
| 18-Feb-16 5:45 PM View: | Regeneron Pharmaceuticals I... (REGN) | 16-Feb-16 | Market Purchase | 81,157 | $391.23 | $31,751,200.00 | < 1% 23.19M to 23.27M | 25% |
| 03-Feb-16 7:00 AM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Feb-16 | Market Purchase | 205,030 | $69.75 | $14,300,800.00 | 2% 10.05M to 10.26M | 20% |
| 14-Jan-16 5:46 PM View: | Regeneron Pharmaceuticals I... (REGN) | 12-Jan-16 | Market Purchase | 83,938 | $465.04 | $39,034,700.00 | < 1% 23.11M to 23.19M | 5% |
| 18-Nov-15 2:26 PM View: | Voyager Therapeutics, Inc. (VYGR) | 16-Nov-15 | Purchase | 125,000 | $14.00 | $1,750,000.00 | 5% 2.35M to 2.48M | |
| 18-Nov-15 2:26 PM View: | Voyager Therapeutics, Inc. (VYGR) | 10-Nov-15 | Conversion | 2,352,940 | -- | -- | 100% 0 to 2.35M | |
| 05-Nov-15 2:37 PM View: | Myokardia, Inc. (MYOK) | 03-Nov-15 | Conversion | 2,318,900 | -- | -- | 100% 0 to 2.32M | |
| 05-Nov-15 2:37 PM View: | Myokardia, Inc. (MYOK) | 03-Nov-15 | Purchase | 900,000 | $10.00 | $9,000,000.00 | 39% 2.32M to 3.22M | |
| 08-Oct-15 5:45 PM View: | Regeneron Pharmaceuticals I... (REGN) | 06-Oct-15 | Market Purchase | 80,538 | $459.71 | $37,024,200.00 | < 1% 23.02M to 23.1M | 6% |
| 08-Oct-15 5:50 PM View: | Regeneron Pharmaceuticals I... (REGN) | 06-Oct-15 | Market Purchase | 11,040 | $472.33 | $5,214,520.00 | < 1% 23.1M to 23.11M | 4% |
| 25-Sep-15 5:45 PM View: | Regeneron Pharmaceuticals I... (REGN) | 23-Sep-15 | Market Purchase | 147,209 | $534.67 | $78,708,600.00 | < 1% 22.87M to 23.02M | (9%) |
| 29-Jul-15 5:46 PM View: | Regeneron Pharmaceuticals I... (REGN) | 27-Jul-15 | Market Purchase (Planned) | 10,639 | $537.48 | $5,718,270.00 | < 1% 22.86M to 22.87M | (9%) |
| 02-Feb-15 1:10 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 29-Jan-15 | Market Purchase | 97,118 | $95.00 | $9,226,210.00 | < 1% 9.95M to 10.05M | (12%) |
| 28-Jan-15 6:51 AM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 26-Jan-15 | Market Purchase | 647,448 | $95.00 | $61,507,600.00 | 7% 9.31M to 9.95M | (12%) |
| 28-Jan-15 6:51 AM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Jan-15 | Purchase | 196,251 | $9,317.00 | $1,828,470,016.00 | 2% 9.11M to 9.31M | |
| 29-Dec-14 5:40 PM View: | Regeneron Pharmaceuticals I... (REGN) | 24-Dec-14 | Market Purchase | 30,002 | $398.79 | $11,964,500.00 | < 1% 22.83M to 22.86M | 23% |
| 29-Dec-14 5:40 PM View: | Regeneron Pharmaceuticals I... (REGN) | 23-Dec-14 | Market Purchase | 171,457 | $392.23 | $67,251,104.00 | < 1% 22.66M to 22.83M | 25% |
| 20-Oct-14 5:45 PM View: | Regeneron Pharmaceuticals I... (REGN) | 16-Oct-14 | Market Purchase (Planned) | 122,127 | $335.35 | $40,955,100.00 | < 1% 22.54M to 22.66M | 46% |
| 17-Oct-14 5:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 15-Oct-14 | Market Purchase (Planned) | 158,368 | $328.16 | $51,970,300.00 | < 1% 22.38M to 22.54M | 49% |
| 18-Sep-14 5:45 PM View: | Regeneron Pharmaceuticals I... (REGN) | 16-Sep-14 | Market Purchase | 31,717 | $349.26 | $11,077,600.00 | < 1% 22.35M to 22.38M | 40% |
| 16-Sep-14 5:45 PM View: | Regeneron Pharmaceuticals I... (REGN) | 15-Sep-14 | Market Purchase | 80,824 | $343.98 | $27,802,200.00 | < 1% 22.26M to 22.35M | 42% |
| 16-Sep-14 5:45 PM View: | Regeneron Pharmaceuticals I... (REGN) | 12-Sep-14 | Market Purchase | 59,808 | $346.73 | $20,737,500.00 | < 1% 22.2M to 22.26M | 41% |
| 17-Jul-14 5:50 PM View: | Regeneron Pharmaceuticals I... (REGN) | 15-Jul-14 | Market Purchase (Planned) | 129,100 | $314.92 | $40,656,200.00 | < 1% 22.08M to 22.2M | 55% |
| 15-Jul-14 5:45 PM View: | Regeneron Pharmaceuticals I... (REGN) | 14-Jul-14 | Market Purchase (Planned) | 150,000 | $318.18 | $47,726,800.00 | < 1% 21.93M to 22.08M | 54% |